Cardiovascular toxicity in breast cancer patients – contributors and role of cardioprotective drugs
| Autor: | Miguel Martins Carvalho, Ricardo Alves Pinto, Tânia Proença, Inês Costa, Nuno Tavares, Mariana Paiva, Carla Sousa, Filipe Macedo |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Monaldi Archives for Chest Disease (2023) |
| Druh dokumentu: | article |
| ISSN: | 1122-0643 2532-5264 |
| DOI: | 10.4081/monaldi.2023.2514 |
| Popis: | Breast cancer (BC) patients treated with anthracyclines and/or anti-HER2-targeted therapies (AHT) are highly associated with cardiovascular toxicity (CVT). Our objective was to evaluate the risk of CVT secondary to cancer treatment and the role of cardioprotective-drugs (CPD) in BC patients. We collected a retrospective cohort of females with BC treated with chemotherapy and/or AHT from 2017 to 2019. CVT was defined as LVEF |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|